Andreessen Horowitz January 10, 2025
Andreessen Horowitz (a16z) Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech Ecosystem Venture Fund (“Fund”) seeks to drive transformative progress in healthcare by investing in therapeutic platforms and cutting-edge technology companies that can bring new medicines and disease treatments to improve patients’ lives. Managed by a16z Bio + Health, the Fund will deploy up to $500 million to invest in companies at all stages – from company creation to growth. The Fund will focus on advancing the development of new medicines, enabling novel modality platforms, and scaling emerging health technologies. As a complementary source of capital to traditional venture...
Today's Sponsors
Today's Sponsor